Vericel (VCEL)
(Delayed Data from NSDQ)
$35.63 USD
+0.69 (1.97%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $35.64 +0.01 (0.03%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth D Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
VCEL 35.63 +0.69(1.97%)
Will VCEL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for VCEL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VCEL
Vericel Corporation (VCEL) Reports Q2 Loss, Lags Revenue Estimates
Wave Life Sciences (WVE) Reports Q2 Loss, Misses Revenue Estimates
VCEL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Vericel Corporation (VCEL) Reports Q1 Loss, Misses Revenue Estimates
Halozyme Therapeutics (HALO) Surpasses Q1 Earnings and Revenue Estimates
Travere Therapeutics (TVTX) Reports Q1 Loss, Tops Revenue Estimates
Other News for VCEL
Vericel (VCEL) Price Target Reduced Despite Solid Earnings
Vericel price target lowered by $3 at Canaccord, here's why
Canaccord Genuity Lowers Price Target on Vericel (VCEL) but Maintains 'Buy' Rating | VCEL Stock News
Vericel Corp (VCEL) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansions
Decoding Vericel Corp (VCEL): A Strategic SWOT Insight